Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
NECB's RSI(14) currently reads 52. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. As with any single metric, weigh this alongside NECB's full indicator set. → Learn more
ADX currently reads 12. ADX tells you how convincing a trend is, leaving the up-or-down call to +DI/-DI (25+ is considered pronounced). Right now NECB shows +DI sits above -DI, favoring the upside, putting it in the 'weak trend' range on ADX. Cross-check this against NECB's other indicators above before drawing a conclusion. → Learn more
NECB's Bollinger Band width is in the bottom 12% (narrow) of its past year, and the squeeze indicator is currently active. This measures how tight the recent trading range is relative to where it normally sits. A squeeze is often followed by a volatility expansion in either direction. As with any single metric, weigh this alongside NECB's full indicator set. → Learn more
NECB's OBV is currently rising (1.2x), and the up/down volume ratio is 1.2x. OBV is a running tally that infers buying or selling pressure purely from volume direction. Treat this as one data point on NECB, not a standalone signal. → Learn more
NECB's recent volume is running at 0.6x its usual level. This ratio shows how many times normal volume the stock has been trading at lately — a reference point for whether order flow is concentrating around this stock. Treat this as one data point on NECB, not a standalone signal. → Learn more
NECB's change over the last 5 trading days is +1.5%, and over the last 1 trading day is -1.6%. These two numbers show recent short-term direction but say nothing about where the price goes next.
NECB's current price is 2.4% below its 20-day high. It shows how much room remains between the current price and its own 20-day high-water mark. On this measure it currently falls in the 'near resistance' category. As with any single metric, weigh this alongside NECB's full indicator set. → Learn more
NECB's ATR% currently reads 2.1%, a 'daily range' level. ATR% expresses how large the average daily move has been recently, as a percentage of price. This reading is specific to NECB on this scan date and can change quickly. → Learn more
NECB's 20-trading-day relative strength versus SPY (S&P 500 ETF) is +2.0%. This means the stock's return beat SPY's return over the same window. Treat this as one data point on NECB, not a standalone signal. → Learn more
Stocks holding Bollinger Band Squeeze reached +15% 28.3% of the time, versus a 29.3% base rate — not a statistically significant difference (3949 cases). As with any single metric, weigh this alongside NECB's full indicator set. → Bollinger Band Squeeze
Measured (n=6001), the hit-rate for OBV Accumulation (26.5%) was not statistically distinguishable from the base rate (29.3%). Treat this as one data point on NECB, not a standalone signal. → OBV Accumulation
Measured (n=8370), the hit-rate for +DI Dominance (27.0%) was not statistically distinguishable from the base rate (29.3%). Cross-check this against NECB's other indicators above before drawing a conclusion. → +DI Dominance
No significant edge was measured for Weekly Squeeze: 25.4% versus a 29.3% base rate across 5281 cases. This reading is specific to NECB on this scan date and can change quickly. → Weekly Squeeze
Measured (n=2081), the hit-rate for Weekly Tight Base 3+ Weeks (2.0%) was not statistically distinguishable from the base rate (29.3%). Cross-check this against NECB's other indicators above before drawing a conclusion. → Weekly Tight Base 3+ Weeks
Stocks holding Stage 2 Trend Template reached +15% 21.4% of the time, versus a 29.3% base rate — not a statistically significant difference (1385 cases). Cross-check this against NECB's other indicators above before drawing a conclusion. → Stage 2 Trend Template
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (NECB diagnostic as of 2026.09.09 15:20).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.